Pharmaceutical & Life Sciences News

DEA to Permit More Production of Controlled Substances for Virus

April 7, 2020, 8:02 PM

The DEA is increasing its controlled substances quotas for drugmakers for use in treating Covid-19 patients, the agency says in a statement.

  • Quotas will be increased by 15% for substances including, fentanyl, morphine, hydromorphone, codeine, ephedrine, pseudoephedrine, and other substances essential to their production: statement
  • DEA will also approve increases in imports of medications for patients on ventilators

To contact the reporter on this story:
Teaganne Finn in Washington at tfinn19@bloomberg.net

To contact the editors responsible for this story:
Kasia Klimasinska at kklimasinska@bloomberg.net

Catherine Dodge, Teaganne Finn

© 2020 Bloomberg L.P. All rights reserved. Used with permission.

To read more articles log in. To learn more about a subscription click here.